Evidence map›Paper›PMID 33837402›Full record

ArticleGenetics2021

The fitness costs and benefits of trisomy of each Candida albicans chromosome.

Feng Yang, Robert T Todd, Anna Selmecki, Yuan-Ying Jiang, Yong-Bing Cao, Judith Berman

Abstract read
In one paragraph

Article in Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Insights on molecular drivers of phenotypic plasticity in Candidozyma auris.World journal of microbiology & biotechnology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Aneuploidy enables adaptation to brefeldin A inFrontiers in cellular and infection microbiology · 2025
    Article
  13. Dual adaptive strategies inFrontiers in microbiology · 2025
    Article
  14. Induction of pan-azole resistance inFrontiers in cellular and infection microbiology · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. The pathobiology of human fungal infections.Nature reviews. Microbiology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feng YangDepartment of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Robert T ToddDepartment of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0002-4522-7124
Anna SelmeckiDepartment of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.ORCID 0000-0003-3298-2400
Yuan-Ying JiangDepartment of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Yong-Bing CaoInstitute of Vascular Disease, Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200086, China.
Judith BermanShmunis School of Biomedical and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.ORCID 0000-0002-8577-0084

Funding

Aneuploidy and Acquired Antifungal Drug Resistance in Candida speciesR01AI143689 · NIAID · UNIVERSITY OF MINNESOTA · PI Anna M. Selmecki · 2020 to 2026
$3.2M
NIAID NIH HHS R01 AI143689
6 · The paper itself

Abstract

Candida albicans is a prevalent human fungal pathogen. Rapid genomic change, due to aneuploidy, is a common mechanism that facilitates survival from multiple types of stresses including the few classes of available antifungal drugs. The stress survival of aneuploids occurs despite the fitness costs attributed to most aneuploids growing under idealized lab conditions. Systematic study of the aneuploid state in C. albicans has been hindered by the lack of a comprehensive collection of aneuploid strains. Here, we describe a collection of diploid C. albicans aneuploid strains, each carrying one extra copy of each chromosome, all from the same genetic background. We tested the fitness of this collection under several physiological conditions including shifts in pH, low glucose, oxidative stress, temperature, high osmolarity, membrane stress, and cell wall stress. We found that most aneuploids, under most conditions, were less fit than their euploid parent, yet there were specific conditions under which specific aneuploid isolates provided a fitness benefit relative to the euploid parent strain. Importantly, this fitness benefit was attributable to the change in the copy number of specific chromosomes. Thus, C. albicans can tolerate aneuploidy of each chromosome and some aneuploids confer improved growth under conditions that the yeast encounters in its host niches.

Indexed as

Genetic FitnessTrisomyAntifungal AgentsCandida albicansCandidiasisChromosomes, FungalDrug Resistance, FungalGenome, FungalHost Microbial InteractionsHumansAntifungal Agentsaneuploidyantifungal drugsCandida albicansfitness benefitsfitness costsmonosomytrisomy; tetrasomy

Identifiers

PMID33837402
PMCPMC8225349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.